Authors

• Erika Hamilton (ORCID: https://orcid.org/0000-0002-1911-0336)
• Maria Delioukina
• Igor Bondarenko (ORCID: https://orcid.org/0000-0002-7071-2471)
• Li Zhou (ORCID: https://orcid.org/0000-0002-9147-9357)
• Antoaneta Tomova
• Jonathan Wade Goldman (ORCID: https://orcid.org/0000-0002-4925-8243)
• Toshinari Yamashita (ORCID: https://orcid.org/0000-0002-6479-1660)
• Komal L. Jhaveri (ORCID: https://orcid.org/0000-0003-0472-1254)
• Allison Moreau
• Heather Neumann
• Yoichi Naito (ORCID: https://orcid.org/0000-0002-8490-9064)
• Timothy Anthony Yap (ORCID: https://orcid.org/0000-0002-2154-3309)
• Jessica Tougias
• Feng Liu (ORCID: https://orcid.org/0009-0003-9694-0602)
• Antonio Giordano (ORCID: https://orcid.org/0000-0002-7760-9717)
• Jennifer Park (ORCID: https://orcid.org/0000-0002-1269-739X)
• Shaveta Vinayak (ORCID: https://orcid.org/0000-0001-9197-7316)

Institutions

• APLA Health (US)
• Memorial Sloan Kettering Cancer Center (US)
• The University of Texas MD Anderson Cancer Center (US)
• Harvard University (US)
• University of California, Los Angeles (US)
• Pfizer (United States) (US)
• University of Washington (US)
• Cornell University (US)
• Medical University Plovdiv (BG)
• Kanagawa Prefectural Hospital Organization (JP)
• Kettering University (US)
• Connecting to Care (US)
• Fred Hutch Cancer Center (US)
• Sarah Cannon (US)
• Dana-Farber Cancer Institute (US)
• City Clinical Hospital (RU)
• Tennessee Oncology (US)
• National Cancer Center Hospital East (JP)
• La Jolla Pharmaceutical (United States) (US)
• Plovdiv University (BG)
• Kanagawa Cancer Center

Publication Details

Journal

Clinical Cancer Research

Published

2025-04-17

DOI

https://doi.org/10.1158/1078-0432.ccr-24-2740

Citations

7

Primary Topic

Advanced Breast Cancer Therapies

Type

article

Field-Weighted Citation Impact

10.63

Funders

• Pfizer